Welcome to our dedicated page for QUANTASING GROUP SEC filings (Ticker: QSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The QSG SEC filings page on Stock Titan provides access to historical regulatory documents for QuantaSing Group Limited, which has since rebranded as Here Group Limited and begun trading on the Nasdaq Global Market under the ticker symbol HERE. These filings, submitted primarily under the Exchange Act as a foreign private issuer, document key stages in the company’s evolution from a lifestyle solution provider with online learning services to a pop toy-focused business.
Among the available documents are Form 6-K current reports, which QuantaSing used to furnish press releases and other information to the U.S. Securities and Exchange Commission. Examples include 6-K filings that attach announcements of unaudited quarterly and full-year financial results, the filing of the annual report on Form 20-F, and updates on investments in Shenzhen Yiqi Culture Co., Ltd. (Letsvan), a company engaged in IP incubation, IP operation, copyright commercialization, and the promotion and sales of pop toys and other cultural products for global artists.
Other 6-K filings relate to corporate actions such as business restructuring, the termination of VIE arrangements for individual online learning services in the PRC, share transfer agreements for overseas learning and consumer businesses, and the convening and results of an extraordinary general meeting. Additional filings cover the name change and ticker symbol change from QuantaSing Group Limited (QSG) to Here Group Limited (HERE), including exhibits with the relevant press releases and meeting documentation.
On Stock Titan, users can review these QSG filings in one place and use AI-powered summaries to understand the main points of each document, such as segment shifts, restructuring steps, or the implications of the rebranding. The page also surfaces real-time updates from EDGAR for any remaining historical submissions under QSG and allows users to connect the QSG filing history with the company’s ongoing disclosures under the HERE ticker.
QuantaSing Group Ltd. (NASDAQ: QSG) – Form 144 filing dated 06/27/2025 discloses that DCM VIII LP, an investment vehicle whose general partner is identified as a director-level affiliate of the issuer, intends to sell up to 98,001 American Depositary Receipts (ADRs). At the 06/26/2025 closing price implied in the filing, the proposed sale carries an aggregate market value of US$789,858.66. The shares will be brokered through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate execution date of 06/27/2025.
The filing also reports that, during the prior three months, affiliated DCM funds have already sold a combined 188,074 ADRs for gross proceeds of US$1.69 million. Adding the proposed sale would lift total recent dispositions to roughly 286,000 ADRs. For context, QuantaSing has 311,328,381 ADRs outstanding; therefore, the new Form 144 covers about 0.03 % of the float.
The securities being sold were originally acquired on 04/23/2018 in a private transaction with the issuer for cash consideration. The signer, Andre Levi, certifies that no undisclosed material adverse information is known and acknowledges criminal liability for misstatements under 18 U.S.C. §1001.
No financial performance metrics, earnings data or operational updates are included in this notice; the filing strictly concerns a planned secondary sale by an insider-affiliated holder.
Form 144 filing overview: QuantaSing Group Ltd. (NASDAQ: QSG) received a Rule 144 notice dated 06/27/2025 from DCM Affiliates Fund VIII, LP, an affiliate of a QSG director. The fund plans to dispose of 29,190 American Depositary Receipts (ADRs) through Morgan Stanley Smith Barney on NASDAQ. The proposed sale is valued at $235,262.64 based on the market price at the time of filing.
Historical selling activity: The same group of related DCM entities disclosed sales on 25-26 June 2025 totaling 188,074 ADRs for aggregate gross proceeds of approximately $1.67 million. All sold securities were ADRs identical to the class now being offered.
Scale relative to outstanding shares: QuantaSing reports 311,328,381 ADRs outstanding. The newly-proposed 29,190-ADR sale equals roughly 0.009 % of shares outstanding, while the recent 3-day sales equal about 0.060 %. Although small in percentage terms, the notice confirms continuing insider-related distributions.
Acquisition background: The securities were originally acquired on 04/23/2018 via a private transaction with the issuer for cash.
Key compliance note: By signing the form, the filer certifies that it is not in possession of undisclosed material adverse information and acknowledges potential liability for misstatements under 18 U.S.C. 1001.
QuantaSing Group Ltd. (QSG) – Form 144 Insider Sale Notice
On 27 June 2025, director-related entity DCM Ventures China Fund (DCM VIII) LP filed a Form 144 indicating its intent to sell up to 1,184,735 American Depositary Shares (ADRs) of QuantaSing Group Ltd. The shares will be placed through Morgan Stanley Smith Barney LLC on the NASDAQ. Based on the filing price reference, the proposed sale has an aggregate market value of US$9.55 million.
The issuer reports 311,328,381 ADRs outstanding; the planned disposition therefore represents roughly 0.38 % of total shares—modest in percentage terms, but sizeable in absolute dollar value. The seller originally acquired the shares on 23 April 2018 via a private, cash-funded transaction with the issuer.
Recent insider activity: Within the last three months, DCM-related entities disposed of a combined 188,074 ADRs over 25-26 June 2025, generating gross proceeds of approximately US$1.67 million. The latest Form 144 signals a continuation—and scale-up—of this selling trend.
Key take-aways for investors:
- Although the sale represents less than 1 % of shares outstanding, it adds incremental supply and may weigh on near-term sentiment.
- Because the filing comes from a director-affiliated fund, markets often view the move as a potential indicator of insider outlook or portfolio re-balancing.
- No adverse, non-public information is acknowledged in the certification, and the company’s operations or guidance are not addressed in this document.
Form 144 filing overview: DCM Ventures China Fund (DCM VIII) LP, identified as a director-level affiliate of QuantaSing Group Ltd. (QSG), has filed a Form 144 to sell up to 98,199 American Depositary Receipts (ADRs) of the company.
Transaction specifics
- Broker: Morgan Stanley Smith Barney LLC (Executive Financial Services, New York, NY).
- Proposed sale date: 26 June 2025.
- Aggregate market value of proposed sale: US $847,928.73.
- Shares outstanding: 311,328,381 ADRs.
- The proposed sale therefore represents roughly 0.03 % of total shares outstanding (calculated from figures provided in the filing).
Recent insider sales (past 3 months):
- DCM VIII LP – 5,926 ADRs for US $54,557.72 (25 Jun 2025).
- DCM Affiliates Fund VIII LP – 1,765 ADRs for US $16,249.47 (25 Jun 2025).
- DCM Ventures China Fund (DCM VIII) LP – 71,641 ADRs for US $659,562.87 (25 Jun 2025).
Combining the prior 79,332 ADRs already sold with the newly-filed 98,199 ADRs brings the potential total insider disposition to 177,531 ADRs, still below 0.1 % of shares outstanding.
The signatory, /s/ Andre Levi, confirms compliance with Rule 144 requirements and states that no undisclosed material adverse information is known. No remarks or special conditions are noted.
Key takeaway for investors: The filing signals additional but quantitatively minor insider selling activity by a director-related fund. Given the very small proportion of shares involved, the event is unlikely to have a material impact on QuantaSing’s share structure or trading dynamics, but investors may monitor if the pattern of sales accelerates.
Form 144 filing overview: On 26 June 2025, DCM VIII LP, an investment fund affiliated with a QuantaSing Group Ltd. (NASDAQ:QSG) director, filed a Form 144 indicating its intention to sell up to 8,123 American Depositary Receipts (ADRs). At the price disclosed in the filing, the proposed sale is valued at approximately US$70,140.
Scale of planned sale: The 8,123 ADRs represent roughly 0.0026 % of the company’s 311.3 million shares outstanding, implying negligible dilution or ownership impact. Morgan Stanley Smith Barney LLC will execute the trade, with the transaction targeted for 26 June 2025 on Nasdaq.
Recent insider activity: Related DCM entities sold an aggregate 79,332 ADRs over the prior three months, generating gross proceeds of about US$730,370. Even collectively, these disposals equal only ~0.025 % of shares outstanding, suggesting limited market pressure.
Acquisition background: The securities were originally obtained via a private purchase from the issuer on 23 April 2018 for cash. The filer certified that it holds no undisclosed material adverse information about QuantaSing. The notice was signed by Andre Levi.
Key takeaway: The filing is an administrative notice of a relatively small insider sale; it contains no operational or financial data and does not materially alter the investment thesis on QSG.
QuantaSing Group Ltd. (QSG) – Form 144 filing dated 26 Jun 2025 details a proposed insider sale under Rule 144.
- Seller: DCM Affiliates Fund VIII, LP, identified as a Director-related holder.
- Proposed sale: 2,420 American Depositary Receipts (ADRs) through Morgan Stanley Smith Barney LLC on or about 26 Jun 2025.
- Market value: US $20,896.22 (≈ $8.63 per ADR).
- Share base: 311,328,381 ADRs outstanding; the proposed sale equals ≈0.0008 % of shares outstanding—an immaterial fraction.
- Recent activity: The same fund complex disposed of 79,332 ADRs over the previous day (25 Jun 2025) for gross proceeds of US $730,370.06.
- Acquisition history: The securities were originally acquired in a private transaction on 23 Apr 2018 for cash.
The filing affirms that the seller possesses no undisclosed material adverse information and has signed under penalty of Rule 144 and 18 U.S.C. 1001. No additional financial metrics, earnings data, or strategic developments are provided.
Investor takeaway: While insider selling can signal negative sentiment, the volume (<1 bps of float) and dollar amount are de minimis; therefore, the filing is unlikely to affect market valuation materially. It mainly reflects routine liquidity management by a venture-capital affiliate.
QuantaSing Group Limited (QSG) has filed a Form 144 with the SEC, signaling the proposed sale of 1,765 American Depositary Shares (ADRs) on or about 25 June 2025 through Morgan Stanley Smith Barney on Nasdaq. The aggregate market value of the planned sale is US$16,249.47, versus a total of 311,328,381 shares outstanding, implying a dilution of less than 0.001%.
The seller originally acquired the ADRs in April 2018 via a private, cash-settled transaction with the issuer. No other sales have been reported in the past three months. Form 144 requires the filer to affirm that no undisclosed material adverse information exists. Given the modest size of the transaction relative to the company’s float, the filing appears routine and is unlikely to affect market dynamics.
QuantaSing Group Limited (QSG) filed a Form 144 signaling an intent to sell up to 5,926 American Depositary Receipts (ADRs) through Morgan Stanley Smith Barney on or about 06/25/2025.
The proposed sale carries an aggregate market value of $54,557.72, equating to roughly 0.0019 % of the company’s 311,328,381 shares outstanding. The shares were originally acquired on 04/23/2018 via a private purchase from the issuer for cash. No other sales by this holder have occurred during the past three months.
Given the very small size relative to QuantaSing’s float, the notice appears immaterial to valuation or liquidity and is largely a routine compliance disclosure under Rule 144.